#OnCNBCTV18 | #Q4 should also see a turnover of around ₹3,400 or higher. Margin has hit 18% in the last couple of quarters. Keep FY23 growth target close to 6%, says VS Mani of Glenmark Pharma
#OnCNBCTV18 | #US sales should be around $100 million on a sequential basis. Estimate 10-12% growth for FY24 and margin of around 19%, adds VS Mani of Glenmark Pharma
#GlenmarkPharma
#GlenmarkPharma
Loading suggestions...